Back to search

University of Strathclyde

Radiosensitisation of glioma cells through development of a gold nanoparticle delivery system to inhibit Ataxia telangiectasia mutated (ATM)

Abstract

dc:description.abstract

Patients with brain cancers like glioma have a very poor survival rate and although there are various treatment options, there is still no cure for the disease. Better more effective treatments are therefore needed. Current treatment options include: chemotherapy, radiotherapy, immunotherapy, surgery and a variety of drugs. Recent research has allowed a better understanding of the disease, with more specific, targeted treatments being developed. The ATM repair pathway, responds to radiation induced DNA damage, activating a pathway to repair DNA double stranded breaks (DSBs). Small molecule ATM inhibitors were developed in order to prevent the repair of these radiation induced DNA DSBs, in turn preventing the tumour from repairing itself and thus increasing tumour cell death. There have been numerous studies demonstrated the radiosensitisation potential of ATM kinase inhibitors thus suggesting ATM inhibition has great potential as a cancer therapy in combination with radiotherapy. Until recently due to poor solubility ATM kinase inhibitors had not progressed into clinical trials however an orally administered ATM tyrosine kinase inhibitor was recently developed by AstraZenca and patients are being recruited for a phase 1 clinical trial. There are however concerns of potential side effects and it is thought that ATP-competitive ATM inhibitors may cause severe side effects in vivo than a loss of ATM protein expression. Therefore, we aimed to develop a tumour specific delivery system delivering complementary oligonucleotides specific for ATM to silence ATM protein expression. Gold nanoparticles have been shown to not only acquire at the sites of tumours through their leaky, immature vasculature but also enhance the radiosensitisation potential, making the glioma cells more sensitive to radiation. This study will look at the use of gold nanoparticles as a delivery system of ATM inhibition, in order to prevent radiation induced upregulation of ATM as well as assessing the potential radioenhancement by the gold nanoparticles themselves.

Degree

thesis:*
Name dc:type.qualificationname
mres
Level dc:type.qualificationlevel
masters-pg
Grantor dc:publisher.institution
University of Strathclyde
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Khan, Aneesah M.
Advisor dc:contributor.advisor
  • Boyd, Marie
Author Identifier dc:creator.authoridentifier
  • 201682681

Rights

Identifiers

dc:identifier.*
Identifier
T14951

Chain of custody

source
Harvested from
University of Strathclyde
Base URL
stax.strath.ac.uk/catalog/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Khan, Aneesah M.. Radiosensitisation of glioma cells through development of a gold nanoparticle delivery system to inhibit Ataxia telangiectasia mutated (ATM). masters-pg thesis, University of Strathclyde, 2017. https://stax.strath.ac.uk/concern/theses/vx021f15g